David Romero Selected Research

David Romero Research Topics

4	Asthma (Bronchial Asthma) 11/2022 - 05/2011
2	Dyspnea (Shortness of Breath) 03/2016 - 10/2011
2	Neoplasms (Cancer) 01/2009 - 07/2008
1	Anaphylaxis (Anaphylactic Shock) 11/2022
1	Churg-Strauss Syndrome (Allergic Angiitis) 01/2022
1	Allergic Bronchopulmonary Aspergillosis 01/2022
1	Hyperventilation 01/2021
1	Hypertension (High Blood Pressure) 05/2020
1	Obesity 05/2020
1	COVID-19 01/2020
1	Hidradenitis Suppurativa 12/2017
1	Hypoxia (Hypoxemia) 12/2015
1	Pulmonary Embolism 12/2015
1	Embolism (Embolus) 12/2015
1	Cystic Fibrosis (Mucoviscidosis) 05/2012
1	Bronchiectasis 05/2012
1	Chronic Obstructive Pulmonary Disease (COPD) 10/2011
1	Melanosis (Freckles) 01/2009
1	Sunburn 01/2009
1	Glioblastoma (Glioblastoma Multiforme) 07/2008
1	Carcinoma (Carcinomatosis) 07/2008
1	Kaposi Varicelliform Eruption (Eczema Herpeticum) 01/2005
1	Atopic Dermatitis (Atopic Eczema) 01/2005

2	benralizumabIBA 11/2022 - 01/2022
2	Omalizumab (Xolair)FDA Link 11/2022 - 01/2022
2	Oxygen (Dioxygen)IBA 03/2016 - 10/2011
2	Biomarkers (Surrogate Marker)IBA 12/2015 - 07/2008
1	mepolizumabIBA 11/2022
1	reslizumabIBA 11/2022
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2021
1	CholesterolIBA 05/2020
1	resorcinol (resorcin)IBA 12/2017
1	Interleukin-6 (Interleukin 6)IBA 03/2016
1	Adenosine (Adenocard)FDA LinkGeneric 03/2016
1	AnticoagulantsIBA 12/2015
1	fibrin fragment D (D-dimer)IBA 12/2015
1	Prothrombin (Factor II)IBA 12/2015
1	Plasminogen Activator Inhibitor 1IBA 12/2015
1	P-SelectinIBA 12/2015
1	antithrombin III-protease complexIBA 12/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2012
1	8-epi-prostaglandin F2alphaIBA 10/2011
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2011
1	Sunscreening Agents (Sunscreens)IBA 01/2009
1	Phosphotransferases (Kinase)IBA 07/2008
1	CrizotinibIBA 07/2008
1	pimecrolimus (Elidel)FDA Link 01/2005

2	Biological Therapy 11/2022 - 01/2020
1	Therapeutics 05/2012